相关实验视频
Updated: Jul 20, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
新药及其在批准后10年的性能:系统分析
Bores Manfouo1, Roland Seifert2
1Institute of Pharmacology, Hannover Medical School, Hannover, D- 30625, Germany.
Naunyn-Schmiedeberg's archives of pharmacology
|May 8, 2025
概括
分析2004年至2011年欧洲药物管理局 (EMA) 批准的新药表明,市场上的成功取决于指示,创新,成本和临床数据. 对药物性能和安全性的早期分析对于药物资源分配至关重要.
科学领域:
- 药品市场分析 药品市场分析
- 药物的有效性和实用性评估.
- 卫生经济学 卫生经济学
背景情况:
- 德国有超过1万种药物可供使用,每年批准数量不断增加.
- 许多药物的有效性和实用性仍然值得怀疑,这阻碍了从市场表现中学习.
- 缺乏系统分析可能会浪费制药资源,并批准没有增加患者利益的药物.
研究的目的:
- 分析欧洲药品管理局 (EMA) 批准的新药10年市场演变情况.
- 确定影响创新药物市场成功的因素.
- 为药品销售提供潜在的"红旗"和"绿旗"的洞察力.
主要方法:
- 分析了2004-2011年间EMA批准的190种新药 (不包括特定类别).
- 利用了来自阿尔兹内尔条例报告 (AVR) 和Wissenschaftliches Institut der Ortskrankenkassen (WidO) 的数据,用于处方,销售,DDD和成本.
- 检查了Rote-Hand-Briefe (RHB) 和相关的药物成功 (销量前3000名),包括指示,创新,成本,竞争和临床研究等因素.
主要成果:
- 几乎一半 (49%) 的分析药物满足了成功标准,其中66%在2年内实现了这一目标.
- 30%的药物收到了Rote-Hand-Briefe (RHB),其中84%被认为可能对销售产生影响.
- 成功药物更频繁地与具有影响力的RHBs相关,通常与不良药物反应或指示有关.
结论:
- 新药的市场成功是多因素的,受指示,创新,竞争,成本和药理性质的影响.
- 临床研究数据对疗效和药物不良反应显著影响市场表现.
- 为了评估潜在的新药,需要进行增值的多因素评估.
相关概念视频
01:11Clinical Trials: Overview
2.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.5K
01:25Drug Regulation
1.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.2K
01:19Pharmacovigilance
744
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
744
01:14Time Course of Drug Effect
1.8K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
1.8K
01:28Preclinical Development: Overview
4.0K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.0K
01:26Drug Administration and Therapy Phases: Overview
385
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
385